SDOT: Sadot Group Inc. Reports 2024 Financial Results Which Showed the First Full Year Positive Net Income in the Company’s History https://buff.ly/mOvtaI3 #microcap #commodities
Zacks Small Cap Research
金融服务
Chicago，IL 98 位关注者
Zacks SCR is a division of Zacks Investment Research (ZIR). We provide equity research on small and micro-cap companies.
关于我们
Zacks Small Cap Research provides research coverage on small and micro-cap companies that are under-followed or under-valued by Wall Street. We produce high-quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth.
The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small cap universe.
- 网站
-
https://scr.zacks.com/
Zacks Small Cap Research的外部链接
- 所属行业
- 金融服务
- 规模
- 11-50 人
- 总部
- Chicago，IL
- 类型
- 私人持股
- 领域
- Small Caps、Micro Caps、Equity Research和Investment Research
地点
-
主要
获取路线
10 S Riverside Plaza
#1600
US，IL，Chicago，60606
动态
-
MGRM: Monogram Technologies Reports 4th Quarter and Full Year 2024 Results https://buff.ly/zBBx2No #orthopaedics #medtech
-
CCLD: CareCloud 4Q24 Earnings Review – High-Quality EPS Beat; Turning the Page to Growth https://buff.ly/QigQTYz #healthcare #technology
-
MIRA MIRA Pharmaceuticals Makes Another Pain Management Stride https://buff.ly/F0NnhGI #painmanagement #smallcaps
-
Azitra Inc's COO Travis Whitfill Outlines What's Next for ATR-04 with Senior Analyst John Vandermosten
Azitra's (AZTR) COO Travis Whitfill Outlines What's Next for ATR-04
https://www.youtube.com/
-
Sr. Vice President, OTC Markets Group |Product Management Executive | SME Investor Relations
Virtual Life Sciences Investor Forum Agenda/Registration: https://bit.ly/41onT95 Please join us on Thursday for our quarterly Life Sciences Investor Forum featuring live presentations and 1x1 meetings with executives of biotech, biopharma, immunotherapy and medtech companies. Special thanks to our sponsor Zacks Investment Research, Richard Hantke and moderator Dave Bautz. Presentations are available for replay for 90 days. Agenda/registration: https://bit.ly/41onT95 Cognition Therapeutics, Inc. BIOPHYTIS - Live Healthier Longer Avicanna Inc. (TSX:AVCN) Psy Therapeutics Cocrystal Pharma, Inc. NervGen Pharma Corp. FibroBiologics (Nasdaq: FBLG) Telescope Innovations Corp. Hemostemix Inc. Izotropic Corp. (CSE: IZO | OTCQB: IZOZF) PDS Biotechnology LadRx Corporation Tonix Pharmaceuticals Rafarma Pharmaceuticals #investing #biotech #biopharma #medtech #immunotheraphy
-
-
Azitra Inc's COO Travis Whitfill Gives Outlook on ATR-12 with Senior Analyst John Vandermosten:
Azitra's (AZTR) COO Travis Whitfill Gives Outlook on ATR-12
https://www.youtube.com/
-
ACHV: Achieve Life Sciences 2Q:25 NDA Submission https://buff.ly/zFb555n #cytisinicline #smokingcessation
-
RERE: ATRenew Inc. 4Q24 Earnings Review: EPS as Expected; Investing for Growth to Keep Pace with Accelerating Demand https://buff.ly/jRGRXO5 #recycling #electronics
-
Join us Thursday, March 13th, for live presentations and CEO Chats with #biopharma, #biotech, & #medtech executives, moderated by senior Zacks Life Sciences analysts. Register here: https://buff.ly/gRtSdgf Participants include: ? Cognition Therapeutics, Inc. (Nasdaq: CGTX) ? BIOPHYTIS - Live Healthier Longer (OTC Pink: BPTSY) ? Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) ? Psy Therapeutics (Private) ? Cocrystal Pharma, Inc. (Nasdaq: COCP) ? NervGen Pharma Corp. (OTCQB: NGENF | TSXV: NGEN) ? FibroBiologics (Nasdaq: FBLG) ? Telescope Innovations Corp. (OTCQB: TELIF | CSE: TELI) ? Hemostemix Inc. (OTCQB: HMTXF | TSXV: HEM) ? Izotropic Corp. (CSE: IZO | OTCQB: IZOZF) ? PDS Biotechnology (Nasdaq: PDSB) ? Tonix Pharmaceuticals (Nasdaq: TNXP) ? Rafarma Pharmaceuticals, Inc. (Pink: RAFA)